Public Profile

HanchorBio Inc.

HanchorBio Inc., a leading biotechnology firm headquartered in Taiwan (TW), has been at the forefront of innovative solutions since its establishment. Specialising in advanced biopharmaceuticals and cutting-edge research, the company operates primarily in the Asia-Pacific region, with a growing presence in global markets. Founded in 2015, HanchorBio has achieved significant milestones, including the development of unique therapeutic products that address unmet medical needs. Their core offerings, which include monoclonal antibodies and biologics, are distinguished by their precision and efficacy, setting new standards in the industry. With a strong commitment to research and development, HanchorBio has positioned itself as a key player in the biopharmaceutical landscape, recognised for its contributions to healthcare advancements and patient outcomes.

DitchCarbon Score

How does HanchorBio Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

HanchorBio Inc.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

HanchorBio Inc.'s reported carbon emissions

HanchorBio Inc., headquartered in Taiwan (TW), currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is challenging to assess the company's carbon footprint or its approach to climate action. In the absence of concrete data, it is essential for HanchorBio Inc. to establish clear climate commitments and reduction strategies to align with industry standards and contribute to global sustainability efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HanchorBio Inc.'s primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. HanchorBio Inc. is headquartered in TW, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

HanchorBio Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

GeneScience Pharmaceuticals Co., Ltd.

CN
Chemicals nec
Updated 17 days ago

Novimmune SA

CH
Research and development services (73)
Updated 17 days ago

Phanes Therapeutics, Inc.

US
Research and development services (73)
Updated 3 days ago

Daiichi Sankyo, Inc.

US
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers